Pfizer Logo (Marstacimab 01)
Hympavzi
Product Images NDC 0069-1575
60 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 60 technical images submitted to the FDA as part of the official labeling for Hympavzi (NDC 0069-1575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pfizer Logo (Marstacimab 02)
150 mg Syringe Supplies (Marstacimab 03)
An instructional illustration showing a HYMPAVZI prefilled syringe alongside an alcohol swab, a cotton ball or gauze pad, and a sharps disposal container. The image highlights components commonly used for injection preparation and safe disposal.*
150 mg Syringe Before And After Use (Marstacimab 04)
An instructional diagram showing the HYMPAVZI prefilled syringe before and after use. The syringe components labeled before use include needle cover, barrel, label, plunger rod, and finger grip. After use, the syringe is shown with the needle exposed and the gray plunger stopper visible.*
150 mg Syringe Step 2 (Marstacimab 05)
An instructional illustration showing a hand holding a small vial or syringe labeled with a lot number and expiration date. The image highlights Step 2: Check Expiration Date, emphasizing the importance of verifying the product's lot number and expiration before use.*
150 mg Syringe Step 3 (Marstacimab 06)
Illustration showing a hand holding a prefilled syringe, labeled as Step 3 'Check Medicine.' The syringe contains liquid medicine and is shown with a needle cover on the tip, demonstrating the step of inspecting the syringe before use.*
150 mg Syringe Step 4 (Marstacimab 07)
Instructional illustration titled 'Choose and Clean Your Injection Site.' It depicts the front and back of a human torso highlighting injection areas: shaded regions on the outer thighs and the abdomen at least 2 inches away from the belly button. The back view shows upper arm areas marked for injection by healthcare providers or caregivers only.*
150 mg Syringe Step 5 (Marstacimab 08)
An instructional illustration labeled Step 5 demonstrating the removal of a cover from a syringe and the insertion of a cap into a circular device. The image shows a hand lifting the syringe cover upward and another hand placing the cap into the device with a downward arrow indicating direction.*
150 mg Syringe Step 6 (Marstacimab 09)
An instructional illustration labeled Step 6 showing how to insert a needle at a 45-degree angle into the skin. The image depicts a syringe held by one hand and the other hand stretching the skin, with an arrow indicating the direction of needle insertion.*
150 mg Syringe Step 7 (Marstacimab 10)
An instructional illustration showing Step 7 for administering medicine via injection. It depicts a hand holding a syringe with the needle inserted into the skin of another hand, indicated by an arrow pointing downward toward the plunger to inject the medicine.*
150 mg Syringe Step 8 (Marstacimab 11)
Illustration showing Step 8 in an injection process for HYMPAVZI. It depicts a hand removing the needle from the injection site on another person's arm, with an upward arrow indicating the needle's removal direction.*
150 mg Syringe Step 9 (Marstacimab 12)
An instructional illustration showing Step 9: Check Syringe. The image depicts a hand holding a syringe, focusing on verifying the syringe contents or setup. This is part of a multi-step procedure likely related to administering or preparing HYMPAVZI medication.*
150 mg Syringe Step 10 (Marstacimab 13)
Illustration showing Step 10 labeled 'After Care,' depicting a hand holding a piece of cotton or gauze, indicating a post-procedure care action likely related to the use of HYMPAVZI.*
150 mg Syringe Step 11 (Marstacimab 14)
An instructional illustration showing Step 11 for disposal of a syringe. The image depicts a hand holding a syringe with a plunger, positioned over a sharps disposal container. A caution symbol indicates not to recap the syringe needle before disposal.*
Pfizer Logo (Marstacimab 15)
150 mg Pen Supplies (Marstacimab 16)
Illustration showing components of the HYMPAVZI prefilled pen system, including the pen device, an alcohol swab, a cotton ball or gauze pad, and a sharps disposal container for safe needle disposal.*
150 mg Pen Before And After Use (Marstacimab 17)
An instructional diagram showing the HYMPAVZI prefilled pen before and after use. The pre-use image labels the cap, needle cover, unlocked needle guard, needle inside guard, window, expiration date, and dose strength. The post-use image labels the locked needle guard, plunger, and yellow bar in the window.*
150 mg Pen Step 2 (Marstacimab 18)
Illustration showing step 2 of a procedure involving a HYMPAVZI injection pen, highlighting how to check the expiration date on the label, with a close-up of the lot number and expiration date formatted as YYYY MMM DD.*
150 mg Pen Step 3 (Marstacimab 19)
An instructional diagram illustrating Step 3 titled 'Check Medicine.' It shows a close-up of a hand peeling back part of a packaging or label to visually inspect a small vial or ampule of medication inside, emphasizing verification of the medicine before use.*
150 mg Pen Step 4 (Marstacimab 20)
An instructional diagram labeled Step 4 illustrating recommended injection sites for HYMPAVZI. It highlights the stomach area (abdomen) with a note to keep injections at least 2 inches away from the belly button, the thigh, and the buttocks. It specifies that injections in the buttocks should be administered by a healthcare provider or caregiver only.*
150 mg Pen Step 5 (Marstacimab 21)
Instructional diagram labeled Step 5 demonstrating the removal of a cap by twisting it off. The illustration shows hands gripping and twisting a cap off a container or device, indicated by blue arrows showing the direction of the twist and the cap's removal.*
150 mg Pen Step 6 (Marstacimab 22)
An instructional diagram illustrating Step 6 of injecting the medicine for HYMPAVZI. It shows how to push down firmly and keep pushing the syringe until two clicks are heard, followed by counting to five as indicated by an hourglass timer icon.*
150 mg Pen Step 7 (Marstacimab 23)
An instructional diagram labeled 'Step 7 Remove Pen' showing a hand holding a pen-like device with the thumb and fingers around it, and a blue arrow pointing upwards indicating the pen should be pulled up and removed.*
150 mg Pen Step 8 (Marstacimab 24)
An instructional illustration labeled Step 8, showing a close-up of a check window on a device containing a yellow liquid. A hand is partially visible interacting with the device, emphasizing the importance of checking the liquid in the window as part of the process.*
150 mg Pen Step 9 (Marstacimab 25)
An instructional illustration labeled Step 9, titled 'After Care,' shows a hand holding a gauze or cotton pad, typically indicating a post-procedure care step such as applying pressure or cleaning a site.*
150 mg Pen Step 10 (Marstacimab 26)
Illustration titled 'Step 10 Disposal of Pen' showing a hand discarding a used injection pen into a round, lidded sharps disposal container. The pen has a white body with a blue cap and a visible yellow band near the middle, emphasizing safe disposal practices.*
Pfizer Logo (Marstacimab 27)
75 mg Syringe Supplies (Marstacimab 28)
75 mg Syringe Before And After Use (Marstacimab 29)
75 mg Syringe Step 2 (Marstacimab 30)
75 mg Syringe Step 3 (Marstacimab 31)
75 mg Syringe Step 4 (Marstacimab 32)
75 mg Syringe Step 5 (Marstacimab 33)
75 mg Syringe Step 6 (Marstacimab 34)
75 mg Syringe Step 7 (Marstacimab 35)
75 mg Syringe Step 8 (Marstacimab 36)
75 mg Syringe Step 9 (Marstacimab 37)
75 mg Syringe Step 10 (Marstacimab 38)
75 mg Syringe Step 11 (Marstacimab 39)
Pfizer Logo (Marstacimab 40)
75 mg Pen Supplies (Marstacimab 41)
75 mg Pen Before And After Use (Marstacimab 42)
75 mg Pen Step 2 (Marstacimab 43)
75 mg Pen Step 3 (Marstacimab 44)
75 mg Pen Step 4 (Marstacimab 45)
75 mg Pen Step 5 (Marstacimab 46)
75 mg Pen Step 6 (Marstacimab 47)
75 mg Pen Step 7 (Marstacimab 48)
75 mg Pen Step 8 (Marstacimab 49)
75 mg Pen Step 9 (Marstacimab 50)
75 mg Pen Step 10 (Marstacimab 51)
Pfizer Logo (Marstacimab 52)
Principal Display Panel – 150 mg/ml Prefilled Pen (Hympavzi 01)
Label for HYMPAVZI 150 mg/mL injection prefilled pen by Pfizer Laboratories Div Pfizer Inc. The label includes the proprietary name HYMPAVZI, the active ingredient marstacimab-hncq, and states it is for subcutaneous use only. It advises storage refrigerated at 36°F to 46°F (2°C to 8°C) and instructs not to shake. The label contains lot, expiration, and barcode information.*
Principal Display Panel – 150 mg/ml Prefilled Pen Carton (Hympavzi 02)
Packaging label for HYMPAVZI 150 mg/mL injection, a single-dose prefilled pen for subcutaneous use. The label features the proprietary name HYMPAVZI with the active ingredient marstacimab-hcnq, includes usage instructions and storage information, and identifies Pfizer Laboratories Div Pfizer Inc as the manufacturer and distributor. The carton also includes barcodes and various regulatory markings.*
Principal Display Panel (150 mg/mL Prefilled Syringe)
Principal Display Panel (150 mg/mL Prefilled Syringe Carton)
Principal Display Panel (75 mg/0.5 mL Prefilled Pen)
Principal Display Panel (75 mg/0.5 mL Prefilled Pen Carton)
Principal Display Panel (75 mg/0.5 mL Prefilled Syringe)
Principal Display Panel (75 mg/0.5 mL Prefilled Syringe Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
